Skip to content
20-F

Annual Report (Foreign)

Belite Bio, Inc BLTE

0001104659-26-037374

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 33.54M sh
Shares Diluted FY 2025 · Dec 31, 2024 30.54M sh
Shares Diluted FY 2025 · Dec 31, 2023 26.59M sh
Shares Outstanding FY 2025 · Dec 31, 2025 39.34M sh
Capex FY 2025 · Dec 31, 2025 $71K
Capex FY 2025 · Dec 31, 2024 $116K
Capex FY 2025 · Dec 31, 2023 $63K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$36.99M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$29.23M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$29.84M
Cash And Equivalents FY 2025 · Dec 31, 2025 $352.93M
Cash And Equivalents FY 2025 · Dec 31, 2024 $31.68M
Stockholders Equity FY 2025 · Dec 31, 2025 $770.49M
Stockholders Equity FY 2025 · Dec 31, 2024 $145.82M
Stockholders Equity FY 2025 · Dec 31, 2023 $90.43M
Stockholders Equity FY 2025 · Dec 31, 2022 $41.5M
Current Liabilities FY 2025 · Dec 31, 2025 $9.88M
Current Liabilities FY 2025 · Dec 31, 2024 $6.05M
Total Liabilities FY 2025 · Dec 31, 2025 $10.07M
Total Liabilities FY 2025 · Dec 31, 2024 $6.31M
Current Assets FY 2025 · Dec 31, 2025 $494.27M
Current Assets FY 2025 · Dec 31, 2024 $147.07M
Total Assets FY 2025 · Dec 31, 2025 $780.56M
Total Assets FY 2025 · Dec 31, 2024 $152.13M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.31
Eps Diluted FY 2025 · Dec 31, 2024 −$1.18
Eps Diluted FY 2025 · Dec 31, 2023 −$1.19
Eps Basic FY 2025 · Dec 31, 2025 −$2.31
Eps Basic FY 2025 · Dec 31, 2024 −$1.18
Eps Basic FY 2025 · Dec 31, 2023 −$1.19
Sga Expense FY 2025 · Dec 31, 2025 $38.83M
Sga Expense FY 2025 · Dec 31, 2024 $10.06M
Sga Expense FY 2025 · Dec 31, 2023 $6.82M
Rd Expense FY 2025 · Dec 31, 2025 $45.38M
Rd Expense FY 2025 · Dec 31, 2024 $29.94M
Rd Expense FY 2025 · Dec 31, 2023 $24.84M
Net Income FY 2025 · Dec 31, 2025 −$77.61M
Net Income FY 2025 · Dec 31, 2024 −$36.14M
Net Income FY 2025 · Dec 31, 2023 −$31.63M
Operating Income FY 2025 · Dec 31, 2025 −$84.21M
Operating Income FY 2025 · Dec 31, 2024 −$40M
Operating Income FY 2025 · Dec 31, 2023 −$31.67M